Authors: Torre, F Campo, N Giusto, R Ansaldi, F Icardi, GC Picciotto, A

Citation: F. Torre et al., Antiviral activity of amantadine in elderly patients with chronic hepatitis C, GERONTOLOGY, 47(6), 2001, pp. 330-333

Authors: Testino, G Ansaldi, F

Citation: G. Testino et F. Ansaldi, Interferon therapy in chronic hepatitis C virus in the prevention of worsening independently of ALT response: Is it conceivable?, HEP-GASTRO, 48(41), 2001, pp. NIL_18-NIL_18

Authors: Setti, M Bruzzone, B Ansaldi, F Borrelli, P Indiveri, F Icardi, G

Citation: M. Setti et al., Identification of key mutations in HIV reverse transcriptase gene can influence the clinical outcome of HAART, J MED VIROL, 64(3), 2001, pp. 199-206

Authors: Ansaldi, F Torre, F Bruzzone, BM Picciotto, A Crovari, P Icardi, G

Citation: F. Ansaldi et al., Evaluation of a new hepatitis C virus sequencing assay as a routine methodfor genotyping, J MED VIROL, 63(1), 2001, pp. 17-21

Authors: Icardi, G Ansaldi, F Bruzzone, BM Durando, P Lee, S de Luigi, C Crovari, P

Citation: G. Icardi et al., Novel approach to reduce the hepatitis C virus (HCV) window period: Clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen, J CLIN MICR, 39(9), 2001, pp. 3110-3114

Authors: Perasso, A Testino, G Ansaldi, F Venturino, V Icardi, GC

Citation: A. Perasso et al., r-interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders, HEPATOLOGY, 29(1), 1999, pp. 297-298